摘要
目的:观察护心康片治疗气虚痰瘀互阻证不稳定型心绞痛(UAP)的临床疗效。方法:将75例气虚痰瘀互阻证UAP患者,随机分为对照组37例和治疗组38例。两组均给予常规西药治疗,治疗组在此基础上加服护心康片,对照组在此基础上加服通心络胶囊,治疗4周后观察两组临床疗效。结果:两组临床疗效和心电图疗效比较,差异有统计学意义(P<0.05);在改善心绞痛症状方面,治疗组优于对照组,差异有统计学意义(P<0.05);在改善中医证候方面,治疗组优于对照组,差异有统计学意义(P<0.05);在改善血脂方面,治疗组优于对照组,差异有统计学意义(P<0.05)。结论:护心康片治疗气虚痰瘀互阻证UAP具有显著疗效,能有效缓解临床症状,改善心肌缺血,提高调节血脂功效。
Objective： To observe the clinical effects of Huxinkang Tablet （：~,,~ ~1~/） in treating unstable angina pectoris （UAP） with the syndrome of Qi deficiency and phlegm and blood stasis （QDPBS）. Method： The 75 patients were randomly divided into the control group （37 cases） and treatment group （38 cases）. All patients were managed with the conventional western medicine. Moreover, the treatment group patients were administered Huxinkang Tablet, while control group patients were administered Tongxinluo Capsules, and the clinical effect of two groups is observed after 4 weeks. Results： Total clinical efficacy and electrocardiograph efficacy between two groups were statistically significant （P〈0.05）. The treatment group had a better curative effect to improve the angina pectoris syndrome, Chinese medicine syndrome and blood fat than the control group （P〈0.05）. Conclusions： Huxinkang Tablet is useful for the clinical treatment of UAP with the syndrome of QDPBS, and can alleviate the clinical syndrome, improve the cardiac muscle and lipid metabolism function.
出处
《中医药导报》
2015年第14期21-24,共4页
Guiding Journal of Traditional Chinese Medicine and Pharmacy
基金
湖南省卫生厅中医药科研基金资助项目(2009041)
关键词
护心康片
不稳定型心绞痛
气虚痰瘀互阻证
血脂
Huxinkang Tablet
Unstable Angina Pectoris
Syndrome of Qi Deficiency and Phlegm and Blood Stasis
Blood Fat
